Oncology & Cancer

Research reveals an immune cell that can attack cancer

According to preclinical research published in Cell researchers at City of Hope have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer.

Oncology & Cancer

The role of fibronectin in BRAF-mutant thyroid cancer treatment

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, Ph.D., could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene—a mutation also ...

Oncology & Cancer

Endometrial cancer: New insights into a deadly disparity

Endometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 ...

Oncology & Cancer

The role of p53 as a target for novel cancer therapies

The p53 tumor suppressor protein is encoded by TP53, the most frequently mutated gene in cancer. A review article published in Nature Reviews Clinical Oncology by Professor Klas G Wiman and colleagues at the Department of ...

page 7 from 40